| « Previous | Back to contents | Next » |
Take with caution
HOME > PAST ISSUE > COVER STORY [Premium content]September 2007
Will recent product safety scandals finally bring order to China’s drug market? Big Pharma has its fingers crossed
Corner-cutting drug makers can no longer get away with murder – at least that was the message the government sent down in July. The execution of Zheng Xiaoyu, the former head of China’s State Food and Drug Administration (SFDA) who was convicted of taking bribes to approve drugs, was a decisive move by Beijing.
In recent times, disgraced top officials have usually had their death sentences commuted to jail terms. Zheng’s execution signaled the government’s ...
log in to continue reading...
 |
| « Previous | Back to contents | Next » |
To receive the best China business news that the market has to offer,
subscribe to the China Economic Review.
subscribe to the China Economic Review.